BRPI0414810A - composições baseadas no vìrus seneca valley e métodos para tratar doença - Google Patents
composições baseadas no vìrus seneca valley e métodos para tratar doençaInfo
- Publication number
- BRPI0414810A BRPI0414810A BRPI0414810-0A BRPI0414810A BRPI0414810A BR PI0414810 A BRPI0414810 A BR PI0414810A BR PI0414810 A BRPI0414810 A BR PI0414810A BR PI0414810 A BRPI0414810 A BR PI0414810A
- Authority
- BR
- Brazil
- Prior art keywords
- svv
- methods
- nucleic acids
- seneca valley
- valley virus
- Prior art date
Links
- 241000837158 Senecavirus A Species 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 6
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108091005461 Nucleic proteins Proteins 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 241000709664 Picornaviridae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000007246 mechanism Effects 0.000 abstract 1
- 244000309459 oncolytic virus Species 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000010415 tropism Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32061—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50618203P | 2003-09-26 | 2003-09-26 | |
| PCT/US2004/031504 WO2005030139A2 (en) | 2003-09-26 | 2004-09-23 | Seneca valley virus based compositions and methods for treating disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0414810A true BRPI0414810A (pt) | 2006-11-14 |
Family
ID=34393123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0414810-0A BRPI0414810A (pt) | 2003-09-26 | 2004-09-23 | composições baseadas no vìrus seneca valley e métodos para tratar doença |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1668025B1 (enExample) |
| JP (1) | JP2007506434A (enExample) |
| KR (1) | KR20060103890A (enExample) |
| CN (1) | CN1875028B (enExample) |
| AU (1) | AU2004275832A1 (enExample) |
| BR (1) | BRPI0414810A (enExample) |
| CA (1) | CA2540177A1 (enExample) |
| DK (1) | DK1668025T3 (enExample) |
| IL (1) | IL174430A0 (enExample) |
| MX (1) | MXPA06003318A (enExample) |
| SG (1) | SG149069A1 (enExample) |
| WO (1) | WO2005030139A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ425699A0 (en) | 1999-11-25 | 1999-12-23 | University Of Newcastle Research Associates Limited, The | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| AU2002953436A0 (en) | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| US7638318B2 (en) | 2003-09-26 | 2009-12-29 | Norvartis Ag | Seneca Valley virus based compositions and methods for treating disease |
| WO2007047256A2 (en) * | 2005-10-13 | 2007-04-26 | Neotropix, Inc. | Svv-based animal vaccines and uses thereof |
| ES2923782T3 (es) | 2015-12-02 | 2022-09-30 | Memorial Sloan Kettering Cancer Center | Oncoterapia dirigida al receptor celular del virus del Valle de Séneca (SVV) |
| CN105925728B (zh) * | 2016-06-01 | 2019-09-20 | 华南农业大学 | 一种塞内加谷病毒实时荧光定量pcr检测引物及试剂盒 |
| US10323069B2 (en) * | 2016-08-23 | 2019-06-18 | Regents Of The University Of Minnesota | Senecavirus A antigens and methods of use |
| CA3069821A1 (en) * | 2017-07-14 | 2019-01-17 | Oncorus, Inc. | Encapsulated polynucleotides and methods of use |
| CN107253978B (zh) * | 2017-08-13 | 2020-11-20 | 中牧实业股份有限公司 | 塞尼卡谷病毒结构蛋白抗体酶联免疫检测试剂盒 |
| CN107513524B (zh) * | 2017-09-30 | 2021-02-09 | 中牧实业股份有限公司 | 一株猪塞内加谷病毒毒株及其应用 |
| CN108467904B (zh) * | 2018-05-24 | 2021-11-19 | 华南农业大学 | 检测塞尼卡谷病毒的rt-lamp引物组、试剂盒及应用 |
| CN109182278B (zh) * | 2018-10-12 | 2021-08-06 | 河南省动物疫病预防控制中心 | 塞尼卡谷病毒毒株及其应用 |
| KR20210093285A (ko) * | 2018-11-13 | 2021-07-27 | 온코루스, 인크. | 캡슐화된 폴리뉴클레오티드 및 사용 방법 |
| CN109234464A (zh) * | 2018-11-23 | 2019-01-18 | 山东新希望六和集团有限公司 | 用于检测塞尼卡谷病毒的引物及探针、荧光定量pcr试剂盒及方法和应用 |
| CN111733144A (zh) * | 2019-03-25 | 2020-10-02 | 金宇保灵生物药品有限公司 | 一种塞内卡病毒的纯化方法及病毒液的浓缩纯化方法 |
| CN110229218B (zh) * | 2019-06-24 | 2020-12-01 | 中国动物疫病预防控制中心(农业农村部屠宰技术中心) | 检测塞内卡病毒抗体的试剂及其所用多肽 |
| US12502414B2 (en) | 2019-07-19 | 2025-12-23 | Seneca Therapeutics, Inc. | Second generation Seneca Valley virus oncolytic therapy: compositions and methods thereof |
| CN110923211A (zh) * | 2019-12-25 | 2020-03-27 | 哈药集团生物疫苗有限公司 | 塞内卡病毒分离株、塞内卡病毒病灭活疫苗及其制备方法 |
| CN111286491A (zh) * | 2020-02-03 | 2020-06-16 | 河南省动物疫病预防控制中心 | 猪塞内卡病毒核酸标准物及其应用 |
| CN111849925B (zh) * | 2020-07-06 | 2022-06-03 | 马忠仁 | 一种抗结肠癌疫苗及其制法 |
| CN111798712B (zh) * | 2020-07-15 | 2021-10-29 | 周晓庆 | 噬菌体侵染细菌3d智能模拟方法 |
| CN111944764A (zh) * | 2020-08-31 | 2020-11-17 | 信阳农林学院 | 一种表达猪塞内加谷病毒蛋白的细胞系、构建方法和应用 |
| CN112390861A (zh) * | 2020-09-30 | 2021-02-23 | 信阳农林学院 | 表达猪塞内加谷病毒vp1蛋白的细胞系、构建方法和应用 |
| CN117281824B (zh) * | 2023-08-11 | 2025-10-21 | 华南农业大学 | Trim基因的过表达剂在制备抑制猪塞内卡病毒复制的产品中的应用 |
| CN117487006B (zh) * | 2023-12-29 | 2024-04-12 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 一种抗a型塞内卡病毒的单克隆抗体以及抗原表位及应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
-
2004
- 2004-09-23 CA CA002540177A patent/CA2540177A1/en not_active Abandoned
- 2004-09-23 EP EP04789044.7A patent/EP1668025B1/en not_active Expired - Lifetime
- 2004-09-23 CN CN200480030443XA patent/CN1875028B/zh not_active Expired - Lifetime
- 2004-09-23 SG SG200809634-9A patent/SG149069A1/en unknown
- 2004-09-23 KR KR1020067008081A patent/KR20060103890A/ko not_active Withdrawn
- 2004-09-23 BR BRPI0414810-0A patent/BRPI0414810A/pt not_active IP Right Cessation
- 2004-09-23 JP JP2006528260A patent/JP2007506434A/ja active Pending
- 2004-09-23 WO PCT/US2004/031504 patent/WO2005030139A2/en not_active Ceased
- 2004-09-23 DK DK04789044.7T patent/DK1668025T3/da active
- 2004-09-23 AU AU2004275832A patent/AU2004275832A1/en not_active Abandoned
- 2004-09-23 MX MXPA06003318A patent/MXPA06003318A/es unknown
-
2006
- 2006-03-21 IL IL174430A patent/IL174430A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1668025A2 (en) | 2006-06-14 |
| MXPA06003318A (es) | 2006-06-08 |
| CN1875028B (zh) | 2012-07-04 |
| IL174430A0 (en) | 2006-08-01 |
| WO2005030139A2 (en) | 2005-04-07 |
| WO2005030139A3 (en) | 2005-10-20 |
| SG149069A1 (en) | 2009-01-29 |
| KR20060103890A (ko) | 2006-10-04 |
| EP1668025A4 (en) | 2007-05-16 |
| HK1094583A1 (en) | 2007-04-04 |
| DK1668025T3 (da) | 2014-08-25 |
| CN1875028A (zh) | 2006-12-06 |
| JP2007506434A (ja) | 2007-03-22 |
| AU2004275832A1 (en) | 2005-04-07 |
| EP1668025B1 (en) | 2014-06-25 |
| CA2540177A1 (en) | 2005-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0414810A (pt) | composições baseadas no vìrus seneca valley e métodos para tratar doença | |
| WO2006101841A3 (en) | Seneca valley virus based compositions and methods for treating disease | |
| Varela et al. | Protein coding assignment of avian reovirus strain S1133 | |
| NO20012223L (no) | Nukleotid- og proteinsekvenser for NOGO-genene og fremgangsmåter basert derpå | |
| BR0113921A (pt) | ácidos nucléicos e polipeptìdeos receptores | |
| PT1404347E (pt) | Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c | |
| ECSP093601A (es) | Proteínas derivadas del virus del síndrome de mancha blanca y sus usos | |
| BRPI0510475A (pt) | adenovìrus quimérico para o uso no tratamento de cáncer | |
| EP1322338A4 (en) | COMPOSITIONS AND METHODS OF USING A CAPSID PROTEIN FROM VARIOUS FLAVIVIRUS AND PESTIVIRUS | |
| BRPI0410870A (pt) | compostos trieterocìclicos, composições, e métodos para tratar cáncer ou doenças virais | |
| BR0015026A (pt) | Indóis substituìdos para a modulação da atividade de nfkb | |
| Terasawa et al. | Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing | |
| CY1112992T1 (el) | Μεσο καλλιεργειας χωρις ορο για την παρασκευη ανασυνδυασμενων γοναδοτροπινων | |
| CY1116413T1 (el) | Καινοφανη πληρως-ανθρωπινα μονοκλωνικα αντισωματα anti-vap-1 | |
| BR9908615A (pt) | Proteìnas codificadas por ácidos polinucléicos de vìrus da sìndrome reprodutiva e respiratória de suìnos (prrsv) | |
| BRPI0407207A (pt) | Método para tratar, prevenir e diagnosticar uma infecção por heliocobacter | |
| WO2005052143A3 (de) | Neue adenoviren, dafür codierende nukleinsäuren und deren verwendung | |
| WO2002042326A8 (en) | A method of expression and agents identified thereby | |
| BRPI0414157A (pt) | polipeptìdeo isolado, ácido nucleico isolado, método para inibir a infecção por vìrus da sìndrome da mancha branca de um crustáceo, e, alimento para um crustáceo | |
| BR0313455A (pt) | modulação "antisense" da expressão de nav1.3 | |
| EA200601043A1 (ru) | Промоторы для экспрессии в модифицированном вирусе осповакцины штамма анкара | |
| CY1109244T1 (el) | Νευρολοιμογονο στελεχος του ιου δυτικου νειλου και εφαρμογες αυτου. | |
| WO2001021807A8 (en) | Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof | |
| BR0112020A (pt) | Partìculas tipo vìrus de bvdv | |
| CY1109206T1 (el) | gM- ΑΡΝΗΤΙΚΟΙ EHV-ΜΕΤΑΛΛΑΚΤΕΣ ΧΩΡΙΣ ΕΤΕΡΟΛΟΓΑ ΣΤΟΙΧΕΙΑ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADE(S) |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |